• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Impact of Type I and III Interferons on Respiratory Superinfections Due to Multidrug-Resistant Pathogens

tetano

Editor, Senior Moderator
J Infect Dis. 2017 Feb 15;215(suppl_1):S58-S63. doi: 10.1093/infdis/jiw466.
[h=1]Impact of Type I and III Interferons on Respiratory Superinfections Due to Multidrug-Resistant Pathogens.[/h] Parker D[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] The increased morbidity and mortality associated with bacterial pneumonias that are acquired following influenza infection are well appreciated by clinicians. One of the major components of the immune response to influenza is the induction of the types I and III interferon cascades, which encompasses the activation of over 300 genes. The immunological consequences of IFN activation, while important for viral clearance, modify the host proinflammatory responses through effects on the inflammasome, Th17 signaling and recruitment of phagocytic cells. IFN signaling affects both susceptibility to subsequent Streptococcus pneumoniae and Staphylococcus aureus infection as well as the intensity of the immune responses associated with pulmonary damage. Appreciation for the effects of IFN activation on anti-bacterial pulmonary defense mechanisms should help to inform therapeutic strategies in an ICU setting.
? The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.


[h=4]KEYWORDS:[/h] Staphylococcus aureus; Streptococcus pneumoniae; influenza; pneumonia; superinfection; type I interferon; type III interferon

PMID: 28375519 DOI: 10.1093/infdis/jiw466
 
Back
Top Bottom